$AET (Aetna Inc.)

$AET {{ '2015-08-04T13:26:28+0000' | timeago}} • Webcast

$AET 2Q15 Call: Our Medicaid business also delivered another strong quarter of results. We grew medical membership by 42,000 members across multiple state programs and delivered pre-tax operating margins near the high end of our targeted range for this business.

$AET {{ '2017-06-21T16:20:19+0000' | timeago}} • Announcement

Healthcare company $AET has signed a collaborative agreement with Community Care Physician Network (CCPN) to develop innovative ways to transform healthcare delivery in North Carolina. As per the deal, Aetna will combine its expertise in alternative value-based delivery models with the advanced medical homes of CCPN physicians, from January 2018.

$AET {{ '2017-05-19T20:29:18+0000' | timeago}} • Announcement

$AET's BoD declared a quarterly cash dividend of $0.50 per share on its common stock. The dividend is payable on July 28, 2017, to shareholders of record at the close of business on July 13, 2017.

$AET {{ '2017-05-02T18:41:05+0000' | timeago}} • Webcast

$AET said there are some developments and conversations underway around its Medicare product as well as its Commercial product, as Aetna gets closer to the Jan 1, 2020 renewal date of the CVS relationship.

$AET {{ '2017-05-02T18:35:35+0000' | timeago}} • Webcast

Even as $AET said it won't provide FY18 guidance, the company continues to see that it will exceed industry growth, especially into January of 2018. Aetna sees fair amount of activity for the 7/1 selling season, and continues to remain focused on national accounts for 2018 as well.

$AET {{ '2017-05-02T18:31:53+0000' | timeago}} • Webcast

$AET, as it posted 1Q17 results, said it plans to continue same-store growth by opening new stores where the company saw a fairly sizable portion of new enrollment in the year. Aetna plans to add more geographies and continue to invest in Star ratings, particularly around service and CAPs in each local market.

$AET {{ '2017-05-02T14:02:27+0000' | timeago}} • Webcast

When asked whether the partnership with $AET will restrict $CVS taking on other large health plans, $CVS commented that currently it services more than 70 health plans. $CVS added that there are some exciting opportunities with $AET's partnership.

$AET {{ '2017-05-02T10:26:20+0000' | timeago}} • Announcement

$AET's adjusted earnings for 1Q17 increased to $939MM from $821MM a year ago. The double-digit percentage increase in adjusted earnings was primarily due to strong performance in the company's Health Care segment, despite the continued pressure in $AET's individual Commercial products.

$AET {{ '2017-05-02T10:26:05+0000' | timeago}} • Announcement

$AET's revenue for 1Q17 decreased by 3% from last year and adjusted revenue declined by 1%. The decrease was primarily due to lower premiums in $AET's Health Care segment, including lower membership in ACA compliant individual and small group products and the temporary suspension of the HIF in 2017.

$AET {{ '2017-05-02T10:25:16+0000' | timeago}} • Announcement

$AET slipped to a loss in 1Q17 from a profit last year, due to costs associated with the termination of $HUM merger agreement. Net loss was $381MM or $1.11 per share compared to a profit of $737MM or $2.08 per share last year. Revenue declined 3% to $15.17Bil. Adjusted EPS increased to $2.71 from $2.32.

$AET {{ '2017-02-27T16:24:54+0000' | timeago}} • Announcement

$AET said it will redeem for cash the entire $750MM of its 3.95% senior notes due Sept. 1, 2020 on or about March 29, 2017. The 2020 notes were issued in August 2010. Payment of the redemption price will be made on or about March 29, 2017. $AET expects to fund the redemption from available cash and short-term debt.

$AET {{ '2017-02-22T15:56:27+0000' | timeago}} • Announcement

$AET entered into accelerated share repurchase agreements with two dealers to repurchase $3.3Bil of its common stock. $AET will pay $1.65Bil to each dealer on Feb. 22, 2017 and will receive from each of them an initial delivery of about 10.4MM shares on the same day. The final settlement of the transaction is expected during or prior to 3Q17.

$AET {{ '2017-02-17T19:45:00+0000' | timeago}} • Announcement

$AET's BoD authorized the company to repurchase up to an additional $4Bil of its common stock. This authorization is in addition to the about $1.1Bil of repurchase authority remaining under the company's existing share repurchase programs.

$AET {{ '2017-02-17T19:44:05+0000' | timeago}} • Announcement

$AET's BoD declared a quarterly cash dividend of $0.50 per share on its common stock, doubling the dividend from the previous quarter. The dividend is payable on April 28, 2017, to shareholders of record on April 13, 2017.

$HUM {{ '2017-02-14T15:19:12+0000' | timeago}} • Announcement

$HUM announced the mutual termination of the merger agreement with $AET. Under the terms of the merger agreement, $HUM is entitled to a breakup fee of $1Bil, or approx $630MM, net of tax.

$HUM {{ '2017-02-08T12:14:06+0000' | timeago}} • Announcement

Following the Jan. 23, 2017 decision from the U.S. District Court of Columbia regarding $HUM's pending transaction with $AET, $HUM now expects to provide its 2017 financial guidance and hold a call to discuss that forecast and provide an update on the transaction with $AET no later than Feb. 16, 2017.

$AET {{ '2017-01-31T19:56:54+0000' | timeago}} • Webcast

$AET did not repurchase shares during 2016 due to the pending $HUM acquisition. For 2017, operating EPS is projected to be at least $8.55 and operating revenue is expected to be $60-61Bil. This guidance represents a standalone scenario assuming there is no $HUM transaction. For 1Q17, membership is estimated to be 22.2-22.3MM medical members.

$AET {{ '2017-01-31T19:37:22+0000' | timeago}} • Webcast

$AET, whose merger with $HUM was blocked recently by the U.S. court, said that it is disappointed with the court's decision. $AET is conducting a thorough review of the court's opinion and considering options for responding to this ruling, including an appeal. The company expects to complete the review prior to the end date of the merger agreement.

$AET {{ '2017-01-31T11:29:11+0000' | timeago}} • Announcement

CEO Mark Bertolini said he has great deal of confidence in $AET's future, including its long-term prospects for growth. As considering next steps in proposed acquisition of $HUM, $AET remains focused on core strategy to deliver innovative, consumer-centric solutions that improve quality, affordability and the overall member experience.

$AET {{ '2017-01-31T11:24:43+0000' | timeago}} • Announcement

$AET reported a 57% drop in 4Q16 earnings due to an increase in restructuring costs, which include expenses related to voluntary early retirement program. Net income fell to $139MM or $0.39 per share from $321MM or $0.91 per share last year. Operating revenue rose 4% to $15.72Bil. Operating EPS increased to $1.63 from $1.37.

$AET {{ '2017-01-30T12:03:31+0000' | timeago}} • Announcement

$AET entered into a four-year reinsurance arrangement with Vitality Re VIII Ltd. as part of its long-term capital management strategy. The arrangement allows $AET to reduce its required capital and provides $200MM of collateralized excess of loss reinsurance coverage on a portion of $AET's group commercial health insurance business.

Recent Transcripts

ATHN (athenahealth, Inc.)
Friday, July 21 2017 - 12:00pm
MSFT (Microsoft Corporation)
Thursday, July 20 2017 - 9:30pm
UNH (UnitedHealth Group Incorporated)
Tuesday, July 18 2017 - 12:45pm
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
CGIX (Cancer Genetics, Inc.)
Friday, May 12 2017 - 1:00pm
RDNT (RadNet, Inc.)
Wednesday, May 10 2017 - 2:30pm
RVNC (Revance Therapeutics, Inc.)
Tuesday, May 9 2017 - 8:30pm
HSIC (Henry Schein, Inc.)
Tuesday, May 9 2017 - 2:00pm
AGN (Allergan plc)
Tuesday, May 9 2017 - 12:30pm
RGLS (Regulus Therapeutics Inc.)
Thursday, May 4 2017 - 9:00pm
MOH (Molina Healthcare, Inc.)
Thursday, May 4 2017 - 9:00pm
RTRX (Retrophin, Inc.)
Thursday, May 4 2017 - 8:30pm
RGEN (Repligen Corporation)
Thursday, May 4 2017 - 12:30pm
REGN (Regeneron Pharmaceuticals, Inc.)
Thursday, May 4 2017 - 12:30pm
HUM (Humana Inc.)
Wednesday, May 3 2017 - 1:00pm
OMI (Owens & Minor Inc.)
Wednesday, May 3 2017 - 12:30pm
WCG (WellCare Health Plans, Inc.)
Wednesday, May 3 2017 - 12:00pm
RIGL (Rigel Pharmaceuticals, Inc.)
Tuesday, May 2 2017 - 9:00pm
CVS (CVS Health Corporation)
Tuesday, May 2 2017 - 12:30pm
AET (Aetna Inc.)
Tuesday, May 2 2017 - 12:30pm

AlphaGraphics you may like